NSE: undefined BSE: undefined
₹-
(-%)
Mon, 27 Apr 2026, 04:27 pm
Company History
2013
- The company was incorporated as 'Anlon Ventures Private Limited'.
2015
- The company changed its name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.
- The company decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs.
2017
- The company received ISO 9001:2015 certification.
- The company started trial production of pharma intermediates and APIs.
2018
- The company commenced commercial production of Pharma Intermediate and API.
- The company made its first export of its product to South Korea.
2019
- The company received Good Manufacturing Practice certification for its Manufacturing Facility.
- The company received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan.
2021
- The company received Good Manufacturing Practice – World Health Organization Certification for its Manufacturing Facility.
2024
- The company received approval for Drug Master File from Brazilian Health Regulatory Agency for its API product loxoprofen sodium dihydrate.
- The company was converted to a public limited company and its name was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800